Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|September 23, 2022
The Role of Sex in Acute and Chronic Liver DamageKatia Sayaf, Daniela Gabbia, Francesco Paolo Russo, et al.
European Journal of Internal Medicine|October 27, 2018
Extrahepatic autoimmunity in autoimmune liver diseaseAnnarosa Floreani, Sara De Martin, Maria Francesca Secchi, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysisSara De Martin, Rocco Orlando, Massimo Bertoli, et al.
Drug Metabolism and Pharmacokinetics|July 13, 2012
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar ratsMaura Floreani, Daniela Gabbia, Massimo Barbierato, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver functionRocco Orlando, Pierpaolo Piccoli, Sara De Martin, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failureRocco Orlando, Sara De Martin, Laura Andrighetto, et al.
Cells|January 11, 2022
The Nuclear Receptor PXR in Chronic Liver DiseaseKatia Sayaf, Ilaria Zanotto, Francesco Paolo Russo, et al.
Trends in Pharmacological Sciences|September 16, 2025
Emerging mechanisms of psilocybin-induced neuroplasticitySonia Sonda, Diana Pendin, Stefano Comai, et al.
Clinical Pharmacology and Therapeutics|May 9, 2006
Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamineRocco Orlando, Roberto Padrini, Mauro Perazzi, et al.
Life Sciences|September 3, 2019
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cellsYahima Frión-Herrera, Daniela Gabbia, Osmany Cuesta-Rubio, et al.
Pageof 10